Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shire Withdraws Replagal BLA Rather Than Conduct Lengthy Trials – Updated

15 Mar 2012

• By Paul Bonanos

Related Content

Genzyme Plant Cleanup Brings Temporary Halt To Fabrazyme, Cerezyme Production

16 Jun 2009

Genzyme’s Framingham Plant Clears FDA; Restoring Full Supply Could Take All Year

30 Jan 2012

<em>Replagal</em> Advisory Committee Will Include Closed Door Session On Manufacturing

27 Feb 2012

Related Companies

Takeda Pharmaceutical Co. Ltd.

Sanofi Genzyme

Sanofi

Additional Topics

United States Ireland Europe Clinical Trials Manufacturing Advisory Committees BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.